𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Real-World Safety and Efficacy of the Endeavor Zotarolimus-Eluting Stent: Early Data From the E-Five Registry

✍ Scribed by Ajay K. Jain; Ian T. Meredith; Chaim Lotan; Martin T. Rothman; Sofia Pateraki

Book ID
113444356
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
133 KB
Volume
100
Category
Article
ISSN
0002-9149

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Extended follow-up safety and effectiven
Extended follow-up safety and effectiveness of the Endeavor zotarolimus-eluting stent in real-world clinical practice: Two-year follow-up from the E-Five Registry
✍ Ian Meredith; Martin Rothman; Andrejs Erglis; Keyur Parikh; Chaim Lotan; for the 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 212 KB 👁 2 views

## Abstract Objectives: To present data from the cohort of patients in the all‐comers Endeavor zotarolimus‐eluting stent (ZES) registry (E‐Five) who underwent 2‐year follow‐up. Background: The Endeavor ZES has been shown to be safe and efficacious for treatment of single, de novo lesions in patient

Real world safety and efficacy of the Ja
Real world safety and efficacy of the Janus tacrolimus-eluting stent: Long-term clinical outcome and angiographic findings from the tacrolimus-eluting stent (TEST) registry
✍ Corrado Tamburino; Maria Elena Di Salvo; Davide Capodanno; Piera Capranzano; Ros 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 2 views

## Abstract ## Objectives: We sought to evaluate the safety and performance of the Janus Tacrolimus‐Eluting stent (TES) in an unselected population of patients, without application of restrictive clinical or angiographic criteria. ## Background: Continued attention to the safety, efficacy, and d

Five-year clinical follow-up after impla
Five-year clinical follow-up after implantation of the endeavor zotarolimus-eluting stent: ENDEAVOR I, first-in-human study
✍ Ian T. Meredith; John Ormiston; Robert Whitbourn; I. Patrick Kay; David Muller; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 2 views

## Abstract Objective: To evaluate the 5‐year clinical outcomes of patients treated with the Endeavor zotarolimus‐eluting stent (ZES) in the ENDEAVOR I first‐in‐human study. Background: ENDEAVOR I was a prospective, nonrandomized, multicenter study of the Endeavor ZES in 100 consecutive patients wi